Sign up for the email list
We just wanted to take a moment to let you know how wonderful Allison Gamber is! She did a training recently at our daughter's school, and had done two... Kris
Landmark Legislation Passes:
October 1, 2011 marked a day that the Epilepsy Foundation of Connecticut, people with epilepsy and all the family and friends of people with epilepsy should long celebrate. With the passage of landmark legislation, Connecticut becomes the first state in the country to require the pharmacist to receive the consent of a physician before substituting epilepsy medication. This new law, which went into effect on October 1st will ensure that people with epilepsy receive a consistent supply of their medication. Prior to passage of this law substitution could and did occur without notice potentially leading to dire and life changing consequences.
Who will this new legislation affect?
What does my doctor need to write on my prescription for the law to apply?
How does the law work?
What happens if my pharmacist doesn’t refill my prescription with the same manufacturer?
Are there multiple manufacturers for some antiepileptic drugs(AED)?
Where do I find the name of the manufacturer of my drug?
Does my doctor and local pharmacist know about this new law?
Does the law apply to switching from brand to generic or generic to generic?
Who should I contact if the pharmacist doesn’t follow the law?
Complaints against a pharmacist can also be directed to: email@example.com
Who is not covered under the law?
Thank You Thank You Thank You
Rep. Betty Boukus (D-Bristol)
Public Health Committee
We are particularly grateful to former State Senator Mary Ann Handley (D-Manchester) who was the chair of the Public Health Committee 4 years ago when we first introduced this legislation. After retiring she returned to offer testimony before her old committee.
We are also grateful to the following organizations who supported our efforts:
Most importantly, we are thankful to Michael Dugan at Capital Consulting and to the many courageous individuals who attended meetings and testified at public hearings.